The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Series A | Alive

Total Raised


Last Raised

$13M | 9 mos ago

About Signos

Signos offers an app-based platform that recommends meals and exercises to help people lose weight based on data from their glucose and metabolic signals. It is based in California, United States.

Signos Headquarter Location


United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Signos

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Signos is included in 3 Expert Collections, including Digital Health.


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health Monitoring & Diagnostics

462 items

Companies developing wearable health monitoring solutions (human health only). Companies tagged as #Wearables (*note: this tag may also apply to companies outside the scope of this collection)


Wellness Tech

1,311 items

We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.

Latest Signos News

Signos Sells a Continuous Glucose Monitor, But Not to Diabetics

May 17, 2022

You may have seen the commercials for FreeStyle Libre devices. Continuous glucose monitors (CGMs) are intended to help improve management of diabetes in patients whose diabetes is not under good control, and also for patients who hate having to keep pricking their finger for blood tests. A small, wearable sensor samples levels of blood glucose in the interstitial fluid (a proxy for […] The post Signos Sells a Continuous Glucose Monitor, But Not to Diabetics first appeared on Science-Based Medicine.

Signos Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Signos Rank

  • What is Signos's latest funding round?

    Signos's latest funding round is Series A.

  • How much did Signos raise?

    Signos raised a total of $17M.

  • Who are the investors of Signos?

    Investors of Signos include Google Ventures, Courtside Ventures, 1984 Ventures and Tau Ventures.

  • Who are Signos's competitors?

    Competitors of Signos include Levels.

You May Also Like


Lumen is a pocket-sized device that measures the gases in users' breath and translates that reading via an app into advice that gives them daily personalized meal plans.

Nutrisense Logo

NutriSense is a metabolic health technology company that aims to help anyone discover and reach their health potential. The company offers a platform that pairs data from continuous glucose monitoring technology with personalized 1-on-1 dietitian coaching that allows members to personalize their nutrition, receive instant feedback to drive behavior change, and deliver an authentic human experience to guide members on their health journey. The company was founded in 2019 and is based in Chicago, Illinois.


January is a precision health company. January provides individuals multidimensional information about their health through its suite of software and consumer products. Using machine learning, the company synthesizes personal data to put control back in the hands of individuals who seek optimal performance and productivity.


Perfood develops personalized, nutrition-based health applications for the digital therapy of diseases. The company serves customers operating in private sector organizations. It was founded in 2017 and is based in Lubeck, Germany.


Lori provides a mobile platform to manage cholesterol issues, hypertension, and diabetes.

Veri Logo

Veri is developing a platform for optimal metabolic health via blood sugar monitoring for people. The company is located in Helsinki, Finland.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.